| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YGYNO.2009.10.059 |
| P698 | PubMed publication ID | 19926121 |
| P2093 | author name string | Sunghoon Kim | |
| Jae Hoon Kim | |||
| Young Tae Kim | |||
| Young Taik Oh | |||
| Jae Wook Kim | |||
| Eun Ji Nam | |||
| Sang Wun Kim | |||
| Mi Jin Yun | |||
| Yong Wook Jung | |||
| P2860 | cites work | Cancer statistics, 2006 | Q29615133 |
| Clinical and surgical staging of non-small cell lung cancer | Q33897552 | ||
| Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Q33957687 | ||
| Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study | Q34008331 | ||
| Multidetector CT of Peritoneal Carcinomatosis from Ovarian Cancer | Q35124938 | ||
| Worldwide burden of gynaecological cancer: the size of the problem | Q36344510 | ||
| Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. | Q36911315 | ||
| Imaging of ovarian cancer | Q40953109 | ||
| Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography | Q46635769 | ||
| Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. | Q51929379 | ||
| Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. | Q53473232 | ||
| The diagnostic value of PET/CT for primary ovarian cancer--a prospective study. | Q53503738 | ||
| Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. | Q53642334 | ||
| Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer | Q57780606 | ||
| Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience | Q67989907 | ||
| Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy | Q68317064 | ||
| A prospective trial of computed tomography in the staging of ovarian malignancy | Q70083701 | ||
| Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre-and postcontrast, fat-suppressed MR imaging, with histologic correlation | Q70548458 | ||
| Image analysis in patients with cancer studied with a combined PET and CT scanner | Q73192965 | ||
| Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer | Q73638511 | ||
| Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group | Q73834872 | ||
| Combined PET/CT Imaging in Oncology. Impact on Patient Management | Q73937935 | ||
| Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group | Q77999921 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| ovarian cancer | Q172341 | ||
| P304 | page(s) | 389-394 | |
| P577 | publication date | 2009-11-18 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. | |
| P478 | volume | 116 |
| Q51748262 | 18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer. |
| Q53096948 | A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer. |
| Q53117341 | A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies. |
| Q39127714 | An update on the role of PET/CT and PET/MRI in ovarian cancer |
| Q52981903 | Analysis of positron emission tomography/computed tomography in patients to differentiate between malignant transformation of endometrioma and endometrioma. |
| Q92379326 | Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study |
| Q36295667 | Benefits of fluorine-18 fludeoxyglucose positron emission tomography in secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer |
| Q92308902 | C-Mannosyl tryptophan increases in the plasma of patients with ovarian cancer |
| Q51417221 | Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases. |
| Q37363520 | Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma |
| Q41667237 | Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells |
| Q58087747 | Detection of Non-small cell Lung Cancer Cells Based on Microfluidic Polarization Microscopic Image Analysis |
| Q55032238 | Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses. |
| Q48105266 | Diagnostic imaging using positron emission tomography for gynecological malignancy. |
| Q26781912 | EMT-Inducing Molecular Factors in Gynecological Cancers |
| Q89473121 | Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study |
| Q90414773 | FDG PET/CT and Conventional Imaging Methods in Cancer of Unknown Primary: an Approach to Overscanning |
| Q53163950 | FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. |
| Q28081482 | Fertility sparing treatment in borderline ovarian tumours |
| Q35906211 | Histopathologic tumor spreading in primary ovarian cancer with modified posterior exenteration |
| Q37989180 | Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach |
| Q37149571 | Intraoperative imaging in ovarian cancer: fact or fiction? |
| Q86108427 | Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients |
| Q38777588 | Nuclear medicine for imaging of epithelial ovarian cancer |
| Q43967086 | PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer. |
| Q53006808 | PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison. |
| Q57780526 | PET/MRI in gynecological tumors |
| Q34442940 | Perimenopausal ovarian carcinoma patient with subclavian node metastasis proven by immunohistochemistry |
| Q53174047 | Preoperative PET/CT in early-stage breast cancer. |
| Q91744535 | Preoperative PET/CT score can predict complete resection in advanced epithelial ovarian cancer: a prospective study |
| Q37813044 | Present and future of FDG-PET/CT in ovarian cancer |
| Q38205397 | Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies |
| Q48211376 | Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer |
| Q59808377 | Prognostic significance of supradiaphragmatic lymph node metastasis detected by F-FDG PET/CT in advanced epithelial ovarian cancer |
| Q37802978 | Radiological Staging of Ovarian Carcinoma |
| Q37940236 | Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors |
| Q82603460 | The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer |
| Q99240948 | The Significance of Preoperative Computed Tomography for Predicting Optimal Cytoreduction in Advanced Ovarian Cancer |
| Q53594556 | The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions. |
| Q37972552 | The preoperative diagnosis of borderline ovarian tumors: a review of current literature. |
| Q35909482 | The role of FDG-PET/CT in gynaecological cancers |
| Q38164208 | The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging |
| Q38957671 | Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer. |
| Q39748368 | Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors. |
Search more.